MFSL Q3 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹14,259 Cr
verified against source
Revenue YoY
—
reported change
EBITDA
Pending
latest reported figure
Source
screener in enriched
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Max Financial Services reported strong Q3 FY26 results with Access Max Life delivering 30% retail AP growth, driven by 52% proprietary channel expansion and 13% partnership growth. VNB margins improved to 24.1% in Q3, expanding 90bps YoY, with 9-month margins at 23.6% (+170bps YoY). The company successfully mitigated ~70-80% of the ~350bps GST disallowance impact through cost actions and product mix adjustments, targeting full recovery over coming quarters. Individual new business sums assured grew 41% to Rs 3.6 lakh crore, while embedded value reached Rs 28,110 crore (+16% YoY). The Insurance Act amendment allowing 100% FDI and permitting insurer-non-insurer mergers is a significant positive, with in-principle board approval received for the Access Max Life-MFSL amalgamation. Key risks include residual GST margin pressure, 13th-month persistency weakness from surrender regulation changes, and regulatory uncertainty around RBI banca circulars. Management maintained FY26 VNB margin guidance of 24-25% and projects continued sales momentum into Q4.
Colored figures show movement against the previous available record.
Guidance to track
- Management reaffirmed full-year guidance, expecting Q4 margins to sustain around current 24.1% levels. Full mitigation of ~350bps GST impact expected over next few quarters.
- With 20% individual adjusted growth in 9M and Q3 acceleration to 30%, management indicated upward revision to sales growth guidance is possible given current trajectory.
- Post-IRDAI regulatory framework issuance and scheme filing, the merger of Access Max Life with MFSL is expected to complete within 12-14 months.
- Early Q4 indicator shows continued strong momentum with 29% company-level growth in January, with equal contribution from proprietary and partnership channels.
Risks flagged
- Q3 13th-month persistency experienced pressure from a specific product category post-surrender regulations, where reduced surrender value created early lapse risk. Management acknowledged this was partially priced into assumptions.
- New RBI circular (night before call) introduces additional misselling safeguards for bancassurance. While existing processes cover most requirements, incremental compliance changes may be needed at bank partner level.
- ~200bps margin headwind from GST remains unmitigated. Management targets complete offset but timeline of 'few quarters' creates earnings uncertainty if execution delays occur.
- Pending IRDAI regulatory framework creates execution uncertainty. Exact structure details remain undisclosed, with management characterizing it as 'premature' to specify.
Key quotes
- We have experienced almost marginally positive operating variance during the quarter on policyholders...we are fairly confident that over few quarters we will be able to mitigate this [GST impact] completely.
- Our 25-month persistency improved to an all-time high of 76% which reflects a nearly 420 basis point year-on-year improvement. These trends underscore the quality of our customer acquisition.
- The new banks like I mentioned across seven banks that we've acquired recently in all the seven banks we have a counter share of more than 25%. In three of those seven banks we've already become the number one player.
Research modules